谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

LBA104 First Safety and Efficacy Results of the TAR-210 Erdafitinib (erda) Intravesical Delivery System in Patients (pts) with Non–muscle-Invasive Bladder Cancer (NMIBC) with Select FGFR Alterations (Alt)

A. Vilaseca, G. Jayram, C. Raventos,N.D. Shore,D. Zainfeld,T.W. Kang,J.H. Ku,J. Meeks,Ó. Rodríguez Faba,F. Roghmann, S. Daneshmand, N. Beeharry, C. Cost, A. Kalota, J. Lauring, M. Peterson, M. Quiroz, N. Stone, W. Zhu,F. Guerrero-Ramos

Annals of oncology（2023）

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要